NCT02204787View on ClinicalTrials.gov

Treatment of Negative Symptoms and Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

October 26, 2018

Study Completion Date

October 26, 2018

Conditions
Schizophrenia
Interventions
DEVICE

transcranial direct current stimulation

Trial Locations (1)

34295

UH Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02204787 - Treatment of Negative Symptoms and Schizophrenia | Biotech Hunter | Biotech Hunter